PT - JOURNAL ARTICLE AU - Jack M. Webster AU - Christine A. Morton AU - Bruce F. Johnson AU - Hua Yang AU - Michael J. Rishel AU - Brian D. Lee AU - Qing Miao AU - Chittari Pabba AU - Donald T. Yapp AU - Paul Schaffer TI - Functional Imaging of Oxidative Stress with a Novel PET Imaging Agent, <sup>18</sup>F-5-Fluoro-<span class="sc">l</span>-Aminosuberic Acid AID - 10.2967/jnumed.113.126664 DP - 2014 Apr 01 TA - Journal of Nuclear Medicine PG - 657--664 VI - 55 IP - 4 4099 - http://jnm.snmjournals.org/content/55/4/657.short 4100 - http://jnm.snmjournals.org/content/55/4/657.full SO - J Nucl Med2014 Apr 01; 55 AB - Glutathione is the predominant endogenous cellular antioxidant, playing a critical role in the cellular defensive response to oxidative stress by neutralizing free radicals and reactive oxygen species. With cysteine as the rate-limiting substrate in glutathione biosynthesis, the cystine/glutamate transporter (system xc-) represents a potentially attractive PET biomarker to enable in vivo quantification of xc- activity in response to oxidative stress associated with disease. We have developed a system xc- substrate that incorporates characteristics of both natural substrates, l-cystine and l-glutamate (l-Glu). l-aminosuberic acid (l-ASu) has been identified as a more efficient system xc- substrate than l-Glu, leading to an assessment of a series of anionic amino acids as prospective PET tracers. Herein, we report the synthesis and in vitro and in vivo validation of a lead candidate, 18F-5-fluoro-aminosuberic acid (18F-FASu), as a PET tracer for functional imaging of a cellular response to oxidative stress with remarkable tumor uptake and retention. Methods: 18F-FASu was identified as a potential PET tracer based on an in vitro screening of compounds similar to l-cystine and l-Glu. Affinity toward system xc- was determined via in vitro uptake and inhibition studies using oxidative stress–induced EL4 and SKOV-3 cells. In vivo biodistribution and PET imaging studies were performed in mice bearing xenograft tumors (EL4 and SKOV-3). Results: In vitro assay results determined that l-ASu inhibited system xc- as well as or better than l-Glu. The direct comparison of uptake of tritiated compounds demonstrated more efficient system xc- uptake of l-ASu than l-Glu. Radiosynthesis of 18F-FASu allowed the validation of uptake for the fluorine-bearing derivative in vitro. Evaluation in vivo demonstrated primarily renal clearance and uptake of approximately 8 percentage injected dose per gram in SKOV-3 tumors, with tumor-to-blood and tumor-to-muscle ratios of approximately 12 and approximately 28, respectively. 18F-FASu uptake was approximately 5 times greater than 18F-FDG uptake in SKOV-3 tumors. Dynamic PET imaging demonstrated uptake in EL4 tumor xenografts of approximately 6 percentage injected dose per gram and good tumor retention for at least 2 h after injection. Conclusion: 18F-FASu is a potentially useful metabolic tracer for PET imaging of a functional cellular response to oxidative stress. 18F-FASu may provide more sensitive detection than 18F-FDG in certain tumors.